ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "ded511d3-16f3-4edf-932c-543fed517e3a"}, "_deposit": {"id": "16294", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "16294"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00016294", "sets": ["456", "1102"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Characteristics of Japanese Hepatocellular Carcinoma"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1998-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "666", "bibliographicPageStart": "661", "bibliographicVolumeNumber": "112", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Recent increase of hepatocellular carcinoma (HCC) is so noticeable, in that hepatitis C virus (HCV) infection contributes to the majority (83%) of the neoplasm. Prospective follow-up study indicates C-viral HCC develops stepwise depending upon the degree or stage of liver fibrosis. Thus, we can predict the chance of developing the neoplasm by liver biopsy staging in C-viral chronic liver disease. Recent introduction of Interferon revealed HCV could be eradicated in 30% of those treated, and reduction in the HCC occurrence among them was demonstrated. These results clearly indicate that, by combining meticulous interventional and medical treatment for HCC and anti-viral therapy for the virus, future development of HCC could be drastically reduced in our country.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "103926", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Omata, Masao"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "小俣, 政男"}], "nameIdentifiers": [{"nameIdentifier": "103925", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "112(11)_661-666.pdf", "filesize": [{"value": "1.0 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1000000.0, "url": {"label": "112(11)_661-666.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/16294/files/112(11)_661-666.pdf"}, "version_id": "e4727828-0040-4894-8807-4003006ef870"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "HCV", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HBV", "subitem_subject_scheme": "Other"}, {"subitem_subject": "HCC", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Interferon", "subitem_subject_scheme": "Other"}, {"subitem_subject": "C型肝炎ウイルス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "B型肝炎ウイルス", "subitem_subject_scheme": "Other"}, {"subitem_subject": "肝細胞癌", "subitem_subject_scheme": "Other"}, {"subitem_subject": "インターフェロン", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "肝癌発生から見た本邦の肝臓病の特徴", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "肝癌発生から見た本邦の肝臓病の特徴"}, {"subitem_title": "肝癌発生から見た本邦の肝臓病の特徴", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1102"], "permalink_uri": "http://hdl.handle.net/10191/46331", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-02-10"}, "publish_date": "2017-02-10", "publish_status": "0", "recid": "16294", "relation": {}, "relation_version_is_last": true, "title": ["肝癌発生から見た本邦の肝臓病の特徴"], "weko_shared_id": null}
  1. 0 資料タイプ別
  2. 03 紀要論文
  1. 250 大学院医歯学総合研究科(医)
  2. 20 紀要
  3. 02 新潟医学会雑誌
  4. 第112巻第11号

肝癌発生から見た本邦の肝臓病の特徴

http://hdl.handle.net/10191/46331
http://hdl.handle.net/10191/46331
f0dd643d-2f40-4577-9b52-7ef791f4ee49
名前 / ファイル ライセンス アクション
112(11)_661-666.pdf 112(11)_661-666.pdf (1.0 MB)
Item type 紀要論文 / Departmental Bulletin Paper(1)
公開日 2017-02-10
タイトル
タイトル 肝癌発生から見た本邦の肝臓病の特徴
タイトル
言語 en
タイトル 肝癌発生から見た本邦の肝臓病の特徴
言語
言語 jpn
キーワード
主題Scheme Other
主題 HCV
キーワード
主題Scheme Other
主題 HBV
キーワード
主題Scheme Other
主題 HCC
キーワード
主題Scheme Other
主題 Interferon
キーワード
主題Scheme Other
主題 C型肝炎ウイルス
キーワード
主題Scheme Other
主題 B型肝炎ウイルス
キーワード
主題Scheme Other
主題 肝細胞癌
キーワード
主題Scheme Other
主題 インターフェロン
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ departmental bulletin paper
その他のタイトル
その他のタイトル Characteristics of Japanese Hepatocellular Carcinoma
著者 小俣, 政男

× 小俣, 政男

WEKO 103925

小俣, 政男

Search repository
著者別名
識別子 103926
識別子Scheme WEKO
姓名 Omata, Masao
抄録
内容記述タイプ Abstract
内容記述 Recent increase of hepatocellular carcinoma (HCC) is so noticeable, in that hepatitis C virus (HCV) infection contributes to the majority (83%) of the neoplasm. Prospective follow-up study indicates C-viral HCC develops stepwise depending upon the degree or stage of liver fibrosis. Thus, we can predict the chance of developing the neoplasm by liver biopsy staging in C-viral chronic liver disease. Recent introduction of Interferon revealed HCV could be eradicated in 30% of those treated, and reduction in the HCC occurrence among them was demonstrated. These results clearly indicate that, by combining meticulous interventional and medical treatment for HCC and anti-viral therapy for the virus, future development of HCC could be drastically reduced in our country.
書誌情報 新潟医学会雑誌
en : 新潟医学会雑誌

巻 112, 号 11, p. 661-666, 発行日 1998-11
出版者
出版者 新潟医学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 00290440
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AN00182415
著者版フラグ
値 publisher
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 15:43:49.588037
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3